Brokerages Set Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Price Target at $18.23

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has been assigned an average recommendation of “Hold” from the fifteen brokerages that are currently covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $20.6923.

A number of analysts have commented on ACHC shares. UBS Group upped their price target on shares of Acadia Healthcare from $24.00 to $27.00 and gave the stock a “buy” rating in a research report on Thursday. KeyCorp cut their price target on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating for the company in a research note on Wednesday, December 3rd. Cantor Fitzgerald set a $17.00 price objective on Acadia Healthcare in a research report on Wednesday, December 3rd. TD Cowen increased their target price on Acadia Healthcare from $22.00 to $24.00 and gave the stock a “buy” rating in a research report on Thursday. Finally, Royal Bank Of Canada boosted their price target on Acadia Healthcare from $17.00 to $28.00 and gave the stock an “outperform” rating in a report on Thursday.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors have recently modified their holdings of the stock. EverSource Wealth Advisors LLC raised its position in shares of Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares during the period. Federated Hermes Inc. boosted its position in Acadia Healthcare by 1.5% during the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after purchasing an additional 668 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Acadia Healthcare by 0.9% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock valued at $1,063,000 after purchasing an additional 696 shares during the period. Public Employees Retirement System of Ohio increased its position in shares of Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after buying an additional 867 shares in the last quarter. Finally, Treasurer of the State of North Carolina raised its stake in shares of Acadia Healthcare by 2.1% during the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock worth $964,000 after buying an additional 867 shares during the period.

Acadia Healthcare News Summary

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q4 revenue topped estimates and EPS beat consensus, driving a strong intraday jump; management provided FY2026 and Q1 2026 guidance that gave investors a clearer outlook. Acadia Healthcare’s (NASDAQ:ACHC) Q4 CY2025 Sales Top Estimates, Stock Jumps 10.8%
• Positive Sentiment: The company posted its Q4 earnings presentation and materials, helping investors parse revenue mix, margin drivers and the path to management’s FY26 targets. Acadia Healthcare Company, Inc. 2025 Q4 – Results – Earnings Call Presentation
• Positive Sentiment: Multiple brokerages raised price targets and maintain buy/outperform stances—RBC to $28 (outperform), UBS to $27 (buy) and TD Cowen to $24 (buy)—which increases buy-side conviction and likely supported the rally. Benzinga: Analyst Price-Target Updates
• Positive Sentiment: Analysts and commentary highlighted improving execution and embedded EBITDA opportunities under returning management, reinforcing the view that operational fixes could restore profitability. TipRanks: Buy Rating on Improving Execution
• Neutral Sentiment: Aggregated analyst coverage: a Benzinga deep-dive summarizes 17 analyst ratings and consensus perspectives — useful for context on how Street expectations are shifting but not a single catalyst. Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
• Negative Sentiment: Short interest remains very large (~32.45M shares as of mid‑Feb, ~35.9% of float) with a ~7.3 days-to-cover ratio — this high short position increases the risk of volatile trading, squeezes, or pressure if execution disappoints. (short-interest reports summarized in filings and market data)

Acadia Healthcare Stock Performance

NASDAQ ACHC opened at $23.44 on Wednesday. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $33.58. The company’s 50 day simple moving average is $14.82 and its two-hundred day simple moving average is $18.57. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.44. The stock has a market capitalization of $2.16 billion, a PE ratio of -1.92, a P/E/G ratio of 7.67 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.03 by $0.04. The company had revenue of $821.46 million for the quarter, compared to analyst estimates of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The firm’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.